Cytokinetics (CYTK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 24,544 | -56,374 | -48,894 | -57,115 | -42,252 |
| Depreciation Amortization | 2,021 | 2,456 | 2,829 | 2,927 | 3,062 |
| Accounts receivable | 41 | -145 | 41,959 | -41,515 | -544 |
| Accounts payable and accrued liabilities | 334 | -6 | -969 | 852 | -191 |
| Other Working Capital | -24,715 | -13,630 | 37,279 | 2,184 | -1,898 |
| Other Operating Activity | 6,191 | 6,371 | -35,209 | 45,497 | 2,339 |
| Operating Cash Flow | $8,416 | $-61,328 | $-3,005 | $-47,170 | $-39,484 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 2,125 | N/A | N/A | N/A | N/A |
| PPE Investments | -476 | -658 | -2,563 | -5,364 | -1,445 |
| Purchase Of Investment | -132,205 | -24,462 | -51,700 | -143,046 | -89,326 |
| Sale Of Investment | 75,970 | 12,607 | 98,729 | 135,527 | 123,995 |
| Other Investing Activity | 1,106 | 2,547 | 996 | -799 | 1,268 |
| Investing Cash Flow | $-53,480 | $-9,966 | $45,462 | $-13,682 | $34,492 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 12,441 | N/A | 1,742 | 4,347 | 1,280 |
| Debt Repayment | -4,279 | -4,050 | -3,888 | -2,873 | -2,410 |
| Common Stock Issued | 13,774 | 599 | 27,324 | 68,295 | 1,054 |
| Common Stock Repurchased | N/A | N/A | N/A | -2 | -25 |
| Other Financing Activity | 6,870 | 0 | 9,542 | 16,957 | 5,547 |
| Financing Cash Flow | $28,806 | $-3,451 | $34,720 | $86,724 | $5,446 |
| Beginning Cash Position | 41,819 | 116,564 | 39,387 | 13,515 | 13,061 |
| End Cash Position | 25,561 | 41,819 | 116,564 | 39,387 | 13,515 |
| Net Cash Flow | $-16,258 | $-74,745 | $77,177 | $25,872 | $454 |
| Free Cash Flow | |||||
| Operating Cash Flow | 8,416 | -61,328 | -3,005 | -47,170 | -39,484 |
| Capital Expenditure | -550 | -658 | -2,563 | -5,370 | -1,465 |
| Free Cash Flow | 7,866 | -61,986 | -5,568 | -52,540 | -40,949 |